On 2025-05-08, Terns Pharmaceuticals, Inc. (TERN) announced earnings per share of $-0.26 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.29.
The next expected annoucement date for quarterly earnings is 2025-08-04, with an average estimated earnings per share of $-0.29 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
---|---|---|---|
2025-05-08 | 2025-03-31 | $-0.29 | $-0.26 |
2025-03-20 | 2024-12-31 | $-0.30 | $-0.24 |
2024-11-12 | 2024-09-30 | $-0.33 | $-0.28 |
2024-08-05 | 2024-06-30 | $-0.35 | $-0.31 |
2024-05-13 | 2024-03-31 | $-0.36 | $-0.30 |
2024-03-14 | 2023-12-31 | $-0.29 | $-0.29 |
2023-11-14 | 2023-09-30 | $-0.31 | $-0.42 |
2023-08-08 | 2023-06-30 | $-0.32 | $-0.25 |
2023-05-15 | 2023-03-31 | $-0.28 | $-0.31 |
2023-03-27 | 2022-12-31 | $-0.42 | $-0.29 |
2022-11-09 | 2022-09-30 | $-0.51 | $-0.44 |
2022-08-08 | 2022-06-30 | $-0.63 | $-0.55 |
2022-05-16 | 2022-03-31 | $-0.67 | $-0.55 |
2022-03-03 | 2021-12-31 | $-0.67 | $-0.56 |
2021-11-15 | 2021-09-30 | $-0.60 | $-0.47 |
2021-08-16 | 2021-06-30 | $-0.81 | $-0.43 |
2021-05-13 | 2021-03-31 | $-0.53 | $-0.88 |
2021-03-30 | 2020-12-31 | $-0.91 | $-3.65 |